Eads & Heald Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-995
Closed -$204K 134
2017
Q3
$204K Sell
995
-119
-11% -$27.7K 0.13% 128
2017
Q2
$271K Sell
1,114
-3
-0.3% -$705 0.17% 118
2017
Q1
$267K Sell
1,117
-414
-27% -$96.4K 0.17% 116
2016
Q4
$322K Sell
1,531
-3,623
-70% -$751K 0.22% 116
2016
Q3
$1.19M Sell
5,154
-163
-3% -$39.8K 0.82% 57
2016
Q2
$1.23M Sell
5,317
-316
-6% -$72.9K 0.84% 58
2016
Q1
$1.51M Sell
5,633
-77
-1% -$22K 1.04% 44
2015
Q4
$1.78M Sell
5,710
-69
-1% -$20.5K 1.24% 26
2015
Q3
$1.57M Sell
5,779
-799
-12% -$245K 1.12% 33
2015
Q2
$2M Sell
6,578
-2,178
-25% -$650K 1.31% 18
2015
Q1
$2.61M Buy
8,756
+2,039
+30% +$581K 1.67% 1
2014
Q4
$1.73M Sell
6,717
-922
-12% -$230K 1.1% 38
2014
Q3
$1.84M Buy
7,639
+460
+6% +$103K 1.25% 31
2014
Q2
$1.6M Sell
7,179
-228
-3% -$47.2K 1.06% 45
2014
Q1
$1.52M Buy
7,407
+323
+5% +$64K 1% 50
2013
Q4
$1.19M Sell
7,084
-270
-4% -$42.2K 0.79% 61
2013
Q3
$1.06M Sell
7,354
-1,203
-14% -$160K 0.76% 67
2013
Q2
$1.08M Buy
+8,557
New +$969K 0.76% 65

Other funds holding AGN

Eads & Heald Wealth Management's AGN Position: Q4 2017 in Review

Eads & Heald Wealth Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 995 shares — an estimated $204K sold.

Eads & Heald Wealth Management first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $2.61M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Eads & Heald Wealth Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 995 Allergan plc shares in Q4 2017, an estimated $204K.
  • Eads & Heald Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
  • Eads & Heald Wealth Management's Allergan plc position peaked at $2.61M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2017, filed 31 Jan 2018.